Evidence map›Paper›PMID 34835670›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Genetic Algorithm-Driven Surface-Enhanced Raman Spectroscopy Substrate Optimization.

Buse Bilgin, Cenk Yanik, Hulya Torun, Mehmet Cengiz Onbasli

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Nanomaterials for Surface Enhanced Raman Spectroscopy.Nanomaterials (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Buse BilginElectrical and Electrical Engineering, Graduate School of Sciences and Engineering, Koç University, Sarıyer, Istanbul 34450, Turkey.ORCID 0000-0002-6260-784X
Cenk YanikSabanci University Nanotechnology Research and Application Center, SUNUM, Tuzla, Istanbul 34956, Turkey.ORCID 0000-0001-5294-6744
Hulya TorunKoç University Research Center for Translational Medicine, Koç University, Sarıyer, Istanbul 34450, Turkey.
Mehmet Cengiz OnbasliElectrical and Electrical Engineering, Graduate School of Sciences and Engineering, Koç University, Sarıyer, Istanbul 34450, Turkey.ORCID 0000-0002-3554-7810

Funding

Scientific and Technological Research Council of Turkey 119S362
6 · The paper itself

Abstract

Surface-enhanced Raman spectroscopy (SERS) is a highly sensitive and molecule-specific detection technique that uses surface plasmon resonances to enhance Raman scattering from analytes. In SERS system design, the substrates must have minimal or no background at the incident laser wavelength and large Raman signal enhancement via plasmonic confinement and grating modes over large areas (i.e., squared millimeters). These requirements impose many competing design constraints that make exhaustive parametric computational optimization of SERS substrates prohibitively time consuming. Here, we demonstrate a genetic-algorithm (GA)-based optimization method for SERS substrates to achieve strong electric field localization over wide areas for reconfigurable and programmable photonic SERS sensors. We analyzed the GA parameters and tuned them for SERS substrate optimization in detail. We experimentally validated the model results by fabricating the predicted nanostructures using electron beam lithography. The experimental Raman spectrum signal enhancements of the optimized SERS substrates validated the model predictions and enabled the generation of a detailed Raman profile of methylene blue fluorescence dye. The GA and its optimization shown here could pave the way for photonic chips and components with arbitrary design constraints, wavelength bands, and performance targets.

Indexed as

genetic algorithmmetasurfacesurface-enhanced Raman spectroscopy

Identifiers

PMID34835670
PMCPMC8618775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.